Prelude Therapeutics Incorporated (PRLD) Stock Price History & Returns
Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)
How Prelude Therapeutics Incorporated (PRLD) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $3.32 sits 37% of the way up a 52-week range of $1.30 to $6.83; 51.4% below the 52-week high; below its 50-day moving average of $4.00; below its 200-day average of $4.10; a beta of 0.96 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
2 of 6 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 18 of 36 months closed higher than the month before. Each figure is the last close in that month.
Prelude Therapeutics Incorporated (PRLD) price history — frequently asked questions
How has Prelude Therapeutics Incorporated performed over the last year?
Prelude Therapeutics Incorporated (PRLD) has risen 124.3% over the last twelve months, measured on price alone.
What is Prelude Therapeutics Incorporated's five-year return?
Over five years the PRLD share price has lost 78.2%, excluding dividends.
What is Prelude Therapeutics Incorporated's 52-week range?
Over the last year Prelude Therapeutics Incorporated (PRLD) has traded between $1.30 and $6.83.
Price returns of other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.